UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025774
Receipt number R000029646
Scientific Title Investigation of Programmed Intermittent Bolus of Lumbar Plexus Block for Total Hip Arthroplasty
Date of disclosure of the study information 2017/02/01
Last modified on 2018/04/02 04:51:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of Programmed Intermittent Bolus of Lumbar Plexus Block for Total Hip Arthroplasty

Acronym

Investigation of PIB of LPB for THA

Scientific Title

Investigation of Programmed Intermittent Bolus of Lumbar Plexus Block for Total Hip Arthroplasty

Scientific Title:Acronym

Investigation of PIB of LPB for THA

Region

Japan


Condition

Condition

Total Hip Arthroplasty

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of effective analgesia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of pushed PCEA
The amount of fentanyl

Key secondary outcomes

Number of requested PCEA
Number of patients used additional analgesi


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

The set flow rate was continuous 6mL of levobupivacaine 0.1% every hour and 6mL levobupivacaine 0.1% lock out time: 60 minutes for 2 days.

Interventions/Control_2

The set flow rate was intermittent bolus of 12mL of levobupivacaine 0.1% every 2 hours and 6mL levobupivacaine 0.1% lock out time: 60 minutes for 2 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who schedule THA

Key exclusion criteria

secondary surgery
bilateral THA

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hironobu Ueshima

Organization

Showa University Hospital

Division name

Anesthesiology

Zip code


Address

1-5-8, Hatanodai, Shinagawa-ku, Tokyo, 142-8666 Japan

TEL

0337848575

Email

ueshimhi@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hironobu Ueshima

Organization

Showa University Hospital

Division name

Anesthesiology

Zip code


Address

1-5-8, Hatanodai, Shinagawa-ku, Tokyo, 142-8666 Japan

TEL

0337848575

Homepage URL


Email

ueshimhi@yahoo.co.jp


Sponsor or person

Institute

Showa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Showa University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 20 Day

Last modified on

2018 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029646


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name